A small number of individual patients have been described with a BCR-JAK2 (Janus Kinase 2) fusion gene leading to CML and other hematological neoplasms, but this fusion gene appears to be rare (see '''[http://atlasgeneticsoncology.org/Anomalies/t0922p24q11ID1331.html] Atlas of Genetics and Cytogenetics in Oncology and Haematology]''') [12,13,14]. | A small number of individual patients have been described with a BCR-JAK2 (Janus Kinase 2) fusion gene leading to CML and other hematological neoplasms, but this fusion gene appears to be rare (see '''[http://atlasgeneticsoncology.org/Anomalies/t0922p24q11ID1331.html] Atlas of Genetics and Cytogenetics in Oncology and Haematology]''') [12,13,14]. |